|
시장보고서
상품코드
1907962
피부 대체물 시장 : 원료별, 세포 함유량별, 사용법별, 용도별, 두께별, 기술별, 최종 사용자별, 지역별Skin Substitute Market, By Source, By Cellular Content, By Use, By Application, By Thickness, By Technology, By End User, By Geography |
||||||
피부 대체물 시장은 2025년에 4억 2,150만 달러로 평가되었고, 2032년까지 7억 5,580만 달러에 이를 것으로 예측됩니다. 2025년부터 2032년까지 연평균 복합 성장률(CAGR) 8.7%로 성장할 것으로 전망되고 있습니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2024년 | 시장 규모(2025년) | 4억 2,150만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2025-2032년 |
| 예측기간 CAGR(2025-2032년) | 8.70% | 예측 금액(2032년) | 7억 5,580만 달러 |
세계의 피부 대체물 시장은 첨단 상처 케어 및 조직 공학 산업의 중요한 부분이며, 손상된 피부 조직을 대체하거나 일시적으로 덮도록 설계된 혁신적인 생물학적 및 합성 재료를 포함합니다.
피부 대체물은 심한 화상, 만성 상처, 당뇨병성 궤양, 정맥성 허벅지 궤양 및 피부 이식이 필요한 다양한 수술로 고통받는 환자에게 필수적인 치료 솔루션으로 작용합니다. 이러한 고급 의료기기는 인간의 피부의 자연적인 특성을 모방하도록 설계되어 보호 장벽을 제공하면서 세포 재생 및 치유 과정을 촉진합니다.
시장에는 인간 또는 동물 유래 생물학적 피부 대체물, 생물학적 물질과 합성 물질을 결합한 생합성 대체물, 중합체 물질로 제조된 순수한 합성물 등 다양한 제품 카테고리가 포함됩니다. 당뇨병 관련 합병증 증가, 만성 상처 위험이 높은 노인 인구 증가, 선진적인 상처 관리 관리에 대한 인식이 높아짐에 따라 피부 대체물 시장은 빠르게 진화하는 분야로 부상하고 있습니다.
의료 종사자들은 기존 치료법에 비해 피부 대체물의 임상적 효과와 비용 효과를 점점 인식하고 있으며, 병원, 전문 상처 케어 센터, 외래 시설에서의 채택을 촉진하고 있습니다. 조직공학, 재생의료, 생체재료과학 등 첨단기술의 통합으로 이 역동적인 시장에서 제품의 성능 향상과 치료 응용 범위의 확대가 계속되고 있습니다.
시장 역학
세계의 피부 대체물 시장은 견고한 성장 궤도와 현대 의료의 임상 중요성을 뒷받침하는 몇 가지 강력한 시장 성장 촉진요인에 의해 견인되고 있습니다. 주요 시장 성장 촉진요인은 세계적으로 증가하는 당뇨병의 유병률에 기인하고 있으며, 당뇨병성 발궤양은 연간 수백만 명의 환자에게 영향을 미치는 주요 합병증으로 치유를 촉진하고 절단을 방지할 수 있는 첨단 상처 케어 솔루션에 대한 큰 수요를 만들어 냈습니다.
또한, 고령화가 진행되는 세계 인구는 만성 상처, 화상, 피부 치환 요법을 필요로 하는 수술에 대한 감수성이 높아지고 있으며, 의료 시스템에서는 입원 기간의 단축과 환자 결과의 개선으로 이어지는 비용 효율적인 치료법의 우선도가 높아지고 있습니다. 조직 공학, 생체 재료 개발 및 재생 의학의 기술적 진보는 혁신을 추진하고 있으며, 생체 적합성, 내구성 및 치료 효과를 향상시킨 보다 발달된 피부 대체물을 창출하고 있습니다.
그러나 시장 성장 억제요인도 존재합니다. 특히 개발도상지역에서는 높은 제품비용이 보급을 방해하고 있으며, 엄격한 규제승인 프로세스가 제품개발기간을 연장시켜 다양한 의료제도에 있어서의 한정적인 상환정책이 의료제공업체와 환자의 채택 의욕을 막고 있습니다.
또한 상처 치유 메커니즘의 복잡성과 다른 피부 대체물에 대한 환자 반응의 변화는 다양한 환자 집단에서 일관된 임상 결과를 달성하는 데 어려움을 겪고 있습니다. 이러한 제약이 있음에도 불구하고, 특히 의료 인프라의 개선과 가처분 소득 증가에 의해 첨단 의료에의 액세스가 확대되고 있는 신흥 경제국에 있어서, 시장 상황에는 큰 기회가 존재합니다. 개인화된 의료 접근법의 개발, 상처 모니터링을 위한 스마트 기술의 통합, 원격 의료 기능의 확장은 시장 성장을 위한 유망한 경로를 보여줍니다. 한편, 줄기세포 기술과 3D 바이오프린팅에 대한 지속적인 연구개발은 피부 대체물의 제조와 커스터마이즈 분야에서 혁신적인 진보를 가져올 가능성을 가지고 있습니다.
목차
제1장 분석 목적과 전제조건
- 분석 목적
- 전제조건
- 약어
제2장 시장 전망
- 보고서 설명
- 시장 정의와 범위
- 주요 요약
제3장 시장 역학, 규제 및 동향 분석
- 시장 역학
- 성장 촉진요인
- 억제요인
- 기회
- 영향 분석
- 주요 발전
- 규제 시나리오
- 제품 출시/승인
- PEST 분석
- Porter's Five Forces 분석
- 기업 합병 및 인수(M&A) 시나리오
- 업계 동향
제4장 세계의 피부 대체물 시장 : 원료별(2020-2032년)
- 생물학적 피부 대체물
- 합성 피부 대체물
- 바이오 합성/하이브리드 피부 대체물
제5장 세계의 피부 대체물 시장 : 세포 함유량별(2020-2032년)
- 무세포성 피부 대체물
- 세포 함유 피부 대체물
제6장 세계의 피부 대체물 시장 : 사용법별(2020-2032년)
- 일시적
- 영구적
제7장 세계의 피부 대체물 시장 : 용도별(2020-2032년)
- 급성 상처
- 만성 상처
- 화상
- 수술창 및 재건
- 외상 및 사고 치료
제8장 세계의 피부 대체물 시장 : 두께별(2020-2032년)
- 표피 대체물
- 진피 대체물
- 2중층(바이 레이어) 대체물
제9장 세계의 피부 대체물 시장 : 기술별(2020-2032년)
- 조직공학 구축체
- 줄기세포 기반 구조체
- 3D 바이오프린트 구조체
- 콜라겐 기반 매트릭스
- 하이드로겔 기반 매트릭스
제10장 세계의 피부 대체물 시장 : 최종 사용자별(2020-2032년)
- 병원
- 화상 전문 센터
- 상처 케어 클리닉
- 외래수술센터(ASC)
- 학술기관 및 연구기관
제11장 세계의 피부 대체물 시장 : 지역별(2020-2032년)
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 아르헨티나
- 멕시코
- 기타 라틴아메리카
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 중동
- GCC 국가
- 이스라엘
- 기타 중동
- 아프리카
- 남아프리카
- 북아프리카
- 중앙 아프리카
제12장 경쟁 구도
- Organogenesis Inc
- Integra LifeSciences Corporation
- Smith Nephew plc
- MiMedx Group Inc
- Tissue Regenix Group plc
- 3M Company
- Vericel Corporation
- AVITA Medical Inc
- PolyNovo Limited
- Stratatech Corporation
- AlloSource
- Acelity LP Inc
- Molnlycke Health Care AB
- Coloplast AS
- ConvaTec Group plc
제13장 애널리스트의 제안
- 기회
- 애널리스트의 견해
- Coherent Opportunity Map(COM)
제14장 참고문헌과 분석 방법
- 참고문헌
- 분석 방법
- Coherent Market Insights에 대해
Skin Substitute Market is estimated to be valued at USD 421.5 Mn in 2025 and is expected to reach USD 755.8 Mn by 2032, growing at a compound annual growth rate (CAGR) of 8.7% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 421.5 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 8.70% | 2032 Value Projection: | USD 755.8 Mn |
The global skin substitute market represents a critical segment within the advanced wound care and tissue engineering industry, encompassing innovative biological and synthetic materials designed to replace or temporarily cover damaged skin tissue.
Skin substitutes serve as essential therapeutic solutions for patients suffering from severe burns, chronic wounds, diabetic ulcers, venous leg ulcers, and various surgical procedures requiring skin grafting. These advanced medical devices are engineered to mimic the natural properties of human skin, providing protective barriers while facilitating cellular regeneration and healing processes.
The market includes various product categories such as biological skin substitutes derived from human or animal sources, biosynthetic alternatives combining biological and synthetic materials, and purely synthetic options manufactured from polymeric substances. With the increasing prevalence of diabetes-related complications, rising geriatric population susceptible to chronic wounds, and growing awareness about advanced wound care management, the skin substitute market has emerged as a rapidly evolving sector.
Healthcare providers increasingly recognize the clinical efficacy and cost-effectiveness of skin substitutes compared to traditional treatment methods, driving adoption across hospitals, specialized wound care centers, and outpatient facilities. The integration of cutting-edge technologies, including tissue engineering, regenerative medicine, and biomaterial sciences, continues to enhance product performance and expand therapeutic applications within this dynamic marketplace.
Market Dynamics
The global skin substitute market is propelled by several compelling drivers that underscore its robust growth trajectory and clinical significance in modern healthcare. The primary market driver stems from the escalating prevalence of diabetes worldwide, with diabetic foot ulcers representing a major complication affecting Mns of patients annually, creating substantial demand for advanced wound care solutions that can expedite healing and prevent amputations.
Additionally, the aging global population presents increased susceptibility to chronic wounds, burns, and surgical procedures requiring skin replacement therapies, while healthcare systems increasingly prioritize cost-effective treatment modalities that reduce hospital stays and improve patient outcomes. Technological advancements in tissue engineering, biomaterial development, and regenerative medicine continue to drive innovation, resulting in more sophisticated skin substitute products with enhanced biocompatibility, durability, and therapeutic efficacy.
However, the market faces significant restraints including high product costs that limit accessibility, particularly in developing regions, stringent regulatory approval processes that extend product development timelines, and limited reimbursement policies in various healthcare systems that discourage adoption among providers and patients.
Furthermore, the complexity of wound healing mechanisms and varying patient responses to different skin substitute materials create challenges in achieving consistent clinical outcomes across diverse patient populations. Despite these constraints, substantial opportunities exist within the market landscape, particularly in emerging economies where healthcare infrastructure improvements and rising disposable incomes are expanding access to advanced medical treatments. The development of personalized medicine approaches, integration of smart technologies for wound monitoring, and expansion of telemedicine capabilities present lucrative avenues for market growth, while ongoing research into stem cell technologies and 3D bioprinting holds promise for revolutionary advances in skin substitute manufacturing and customization.
Market Segmentation
- Source Insights (Revenue, USD Mn, 2020 - 2032)
- Biological Skin Substitutes
- Allograft
- Xenograft
- Autologous
- Synthetic Skin Substitutes
- Polymer-based (e.g., polyurethane, silicone)
- Hydrogel-based
- Foam and film-based
- Biosynthetic/Hybrid Skin Substitutes
- Biological-synthetic composite matrices
- Bioactive polymer-collagen hybrids
- Cellular Content Insights (Revenue, USD Mn, 2020 - 2032)
- Acellular Skin Substitutes
- Cellular Skin Substitutes
- Use Insights (Revenue, USD Mn, 2020 - 2032)
- Temporary
- Permanent
- Application Insights (Revenue, USD Mn, 2020 - 2032)
- Acute Wounds
- Chronic Wounds
- Burn Injuries
- Surgical Wounds and Reconstruction
- Trauma and Accident Care
- Thickness Insights (Revenue, USD Mn, 2020 - 2032)
- Epidermal Substitutes
- Dermal Substitutes
- Double-Layered (Bilayer) Substitutes
- Technology Insights (Revenue, USD Mn, 2020 - 2032)
- Tissue-Engineered Constructs
- Stem Cell-Based Constructs
- 3D Bioprinted Constructs
- Collagen-Based Matrices
- Hydrogel-Based Matrices
- End User Insights (Revenue, USD Mn, 2020 - 2032)
- Hospitals
- Specialty Burn Centers
- Wound Care Clinics
- Ambulatory Surgical Centers
- Academic and Research Institutes
- Regional Insights (Revenue, USD Mn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Organogenesis Inc
- Integra LifeSciences Corporation
- Smith+Nephew plc
- MiMedx Group Inc
- Tissue Regenix Group plc
- 3M Company
- Vericel Corporation
- AVITA Medical Inc
- PolyNovo Limited
- Stratatech Corporation
- AlloSource
- Acelity L P Inc
- Molnlycke Health Care AB
- Coloplast A S
- ConvaTec Group plc
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Skin Substitute Market, By Source
- Global Skin Substitute Market, By Cellular Content
- Global Skin Substitute Market, By Use
- Global Skin Substitute Market, By Application
- Global Skin Substitute Market, By Thickness
- Global Skin Substitute Market, By Technology
- Global Skin Substitute Market, By End User
- Global Skin Substitute Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Skin Substitute Market, By Source, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Biological Skin Substitutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Allograft
- Xenograft
- Autologous
- Synthetic Skin Substitutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Polymer-based (e.g., polyurethane, silicone)
- Hydrogel-based
- Foam and film-based
- Biosynthetic/Hybrid Skin Substitutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Biological-synthetic composite matrices
- Bioactive polymer-collagen hybrids
5. Global Skin Substitute Market, By Cellular Content, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Acellular Skin Substitutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Cellular Skin Substitutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
6. Global Skin Substitute Market, By Use, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Temporary
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Permanent
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
7. Global Skin Substitute Market, By Application, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Acute Wounds
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Chronic Wounds
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Burn Injuries
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Surgical Wounds and Reconstruction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Trauma and Accident Care
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
8. Global Skin Substitute Market, By Thickness, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Epidermal Substitutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Dermal Substitutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Double-Layered (Bilayer) Substitutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
9. Global Skin Substitute Market, By Technology, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Tissue-Engineered Constructs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Stem Cell-Based Constructs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- 3D Bioprinted Constructs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Collagen-Based Matrices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Hydrogel-Based Matrices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
10. Global Skin Substitute Market, By End User, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Specialty Burn Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Wound Care Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
11. Global Skin Substitute Market, By Region, 2020 - 2032, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Cellular Content, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Use, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Thickness, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Cellular Content, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Use, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Thickness, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Cellular Content, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Use, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Thickness, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Cellular Content, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Use, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Thickness, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Cellular Content, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Use, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Thickness, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Cellular Content, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Use, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Thickness, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
12. Competitive Landscape
- Organogenesis Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Integra LifeSciences Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Smith+Nephew plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- MiMedx Group Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Tissue Regenix Group plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- 3M Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Vericel Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AVITA Medical Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PolyNovo Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Stratatech Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AlloSource
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Acelity L P Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Molnlycke Health Care AB
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Coloplast A S
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- ConvaTec Group plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
13. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
14. References and Research Methodology
- References
- Research Methodology
- About us
